Macranthoidin B Modulates Key Metabolic Pathways to Enhance ROS Generation and Induce Cytotoxicity and Apoptosis in Colorectal Cancer

Abstract

Background/Aims: Induction of oxidative stress and reactive oxygen species (ROS) mediated-apoptosis have been utilized as effective strategies in anticancer therapy. Macranthoidin B (MB) is a potent inducer of ROS-mediated apoptosis in cancer, but its mechanism of action is poorly understood. Method: Superoxide production with MB exposure in colorectal cancer (CRC) cells was measured using lucigenin chemiluminescence and real-time PCR. MB’s inhibitory effect on proliferation and viability of CRC cells was determined by proliferation assays. MB’s effect on apoptosis of CRC cells was determined by Western blotting and annexin V-FITC/PI staining. MB’s effect on the growth of CRC xenografts in mice was assessed. An established metabolomics profiling platform combining ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS) with gas chromatography-mass spectrometry (GC-MS) was performed to determine MB’s effect on total metabolite variation in CRC cells. Results: We found that MB increases ROS generation via modulating key metabolic pathways. Using metabolomics profiling platform combining LC-MS with GC-MS, a total of 236 metabolites were identified in HCT-116 cells in which 31 metabolites were determined to be significantly regulated (p ≤ 0.05) after MB exposure. A number of key metabolites revealed by metabolomics analysis include glucose, fructose, citrate, arginine, phenylalanine, and S-adenosylhomocysteine (SAH), suggesting specific modulation of metabolism on carbohydrates, amino acids and peptides, lipids, nucleotide, cofactors and vitamins in HCT-116 CRC cells with MB treatment highly associated with apoptosis triggered by enhanced ROS and activated caspase-3. Conclusion: Our results demonstrate that MB represses CRC cell proliferation by inducing ROS-mediated apoptosis.

Molecular characterization of papillary thyroid carcinoma: a potential three-lncRNA prognostic signature

“…Abnormal regulation of these functions is involved in various cancers, such as lung cancer, breast cancer, bladder cancer and colorectal cancer. 40 – 43 Thus, the abnormal regulation of gene function may play a crucial role in the genesis and progress of PTC. Moreover, we identified three important transcription factors (ELK1, ETV7 and GABPA) that may significantly influence the PTC.…”

Metabolomics biotechnology, applications, and future trends: a systematic review

“…It was found to inhibit colorectal cancer cell proliferation by inducing reactive oxygen species-mediated apoptosis. 47 The problem of cancer has been plaguing humans, and the number of patients dying from cancer is increasing every year. An understanding of cancer mechanisms and appropriate treatments are urgently needed, and emerging technologies will face the enormous challenges of cancer, so there is a long way to go.…”

Molecular Characterization of Advanced Colorectal Cancer Using Serum Proteomics and Metabolomics

“…Similar to proteomics, metabolomics is a large-scale high-throughput omics technology that enables comprehensive and semi-quantitative detection of a large number of metabolites in biological samples. Metabolomic studies in various cancers such as CRC, gastric cancer, liver cancer, and pancreatic cancer have demonstrated its great potentials in improving tumor diagnosis and therapy ( Zheng et al, 2017 ; Fan et al, 2018 ; Zheng et al, 2018 ). For instance, Kim et al performed urine-NMR metabolomics study on 92 patients with colorectal neoplasia and 156 healthy individuals to screen for advanced adenoma and stage 0 CRC ( Kim et al, 2019 ), and the receiver operating characteristics curve analysis results revealed that 3-aminoisobutyrate, taurine, and alanine were good indicators of CRC.…”